Diabetes medications: Impact on inflammation and wound healing

Journal of Diabetes and its Complications

Volumn 30, Issue 4, 2016, Pages 746-752

  Salazar, Jay J ^a   Ennis, William J ^a   Koh, Timothy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

DPP 4 inhibitor; Insulin; Metformin; Sulfonylurea; Thiazolidinedione; Wound healing

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ADIPONECTIN; ANTIDIABETIC AGENT; C PEPTIDE; C REACTIVE PROTEIN; CRYOPYRIN; CYTOKINE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIBENCLAMIDE; GLIMEPIRIDE; GROWTH FACTOR; INSULIN; INSULIN RECEPTOR; INSULIN ZINC SUSPENSION; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PIOGLITAZONE; PLACEBO; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; STROMAL CELL DERIVED FACTOR 1ALPHA; SULFONYLUREA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; CHRONIC WOUND; DIABETIC NEPHROPATHY; EPITHELIZATION; GRANULATION TISSUE; HUMAN; INFLAMMATION; INSULIN LIKE ACTIVITY; INSULIN RESISTANCE; INSULIN TREATMENT; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN INJURY; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UPREGULATION; VASCULARIZATION; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; SECRETION (PROCESS); VASCULITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL; VASCULITIS; WOUND HEALING;

EID: 84955256433     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.12.017     Document Type: Review

References (74)

1. S.Y. Aghdam, S.A. Eming, S. Willenborg, B. Neuhaus, C.M. Niessen, and L. Partridge J.C. Bruning Vascular endothelial insulin/IGF-1 signaling controls skin wound vascularization Biochemical and Biophysical Research Communications 421 2 2012 197 202
2. D.H. Akbar Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome Endocrine 20 3 2003 215 218
3. A. Aljada, J. Friedman, H. Ghanim, P. Mohanty, D. Hofmeyer, A. Chaudhuri, and P. Dandona Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects Metabolism 55 9 2006 1177 1185
4. American Diabetes Association Economic costs of diabetes in the U.S. in 2012 Diabetes Care 36 4 2013 1033 1046
5. S. Apikoglu-Rabus, F.V. Izzettin, P. Turan, and F. Ercan Effect of topical insulin on cutaneous wound healing in rats with or without acute diabetes Clinical and Experimental Dermatology 35 2 2010 180 185
6. M. Arai, M. Uchiba, H. Komura, Y. Mizuochi, N. Harada, and K. Okajima Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro The Journal of Pharmacology and Experimental Therapeutics 334 1 2010 206 213
7. E.A. Attia, D.M. Belal, M.H. El Samahy, and M.H. El Hamamsy A pilot trial using topical regular crystalline insulin vs. aqueous zinc solution for uncomplicated cutaneous wound healing: Impact on quality of life Wound Repair and Regeneration 22 1 2014 52 57
8. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 6 2007 2131 2157
9. J. Bene, A. Jacobsoone, P. Coupe, M. Auffret, S. Babai, and D. Hillaire-Buys S. Gautier Bullous pemphigoid induced by vildagliptin: A report of three cases Fundamental & Clinical Pharmacology 29 1 2015 112 114
10. A. Bitto, D. Altavilla, G. Pizzino, N. Irrera, G. Pallio, M.R. Colonna, and F. Squadrito Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice British Journal of Pharmacology 171 9 2013 2300 2307
11. R. Bressler, and D.G. Johnson Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus Archives of Internal Medicine 157 8 1997 836 848
12. Centers for Disease Control and Prevention National Diabetes Statistics Report: Estimates of diabetes and its burden in the United States, 2014 Retrieved 1 July 2015, from http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf 2014
13. X. Chen, Y. Liu, and X. Zhang Topical insulin application improves healing by regulating the wound inflammatory response Wound Repair and Regeneration 20 3 2012 425 434
14. H. Chen, R. Shi, B. Luo, X. Yang, L. Qiu, J. Xiong, M. Jiang, Y. Liu, Z. Zhang, and Y. Wu Macrophage peroxisome proliferator-activated receptor gamma deficiency delays skin wound healing through impairing apoptotic cell clearance in mice Cell Death & Disease 6 2015 e1597
15. R. Chen, J. Yan, P. Liu, and Z. Wang Effects of thiazolidinedione therapy on inflammatory markers of type 2 diabetes: A meta-analysis of randomized controlled trials PloS One 10 4 2015 e0123703
16. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function Current Opinion in Lipidology 14 5 2003 459 468
17. H.M. Colhoun, S.J. Livingstone, H.C. Looker, A.D. Morris, S.H. Wild, and R.S. Lindsay G. Scottish Diabetes Research Network Epidemiology Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs Diabetologia 55 11 2012 2929 2937
18. P. Dandona, A. Aljada, H. Ghanim, P. Mohanty, C. Tripathy, D. Hofmeyer, and A. Chaudhuri Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin The Journal of Clinical Endocrinology and Metabolism 89 10 2004 5043 5047
19. P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, W. Hamouda, E. Assian, and S. Ahmad Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? The Journal of Clinical Endocrinology and Metabolism 86 7 2001 3257 3265
20. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules P. R. investigators Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial Lancet 366 9493 2005 1279 1289
21. S.A. Eming, P. Martin, and M. Tomic-Canic Wound repair and regeneration: Mechanisms, signaling, and translation Science Translational Medicine 6 265 2014 265sr266
22. E. Faglia, F. Favales, and A. Morabito New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: A 6.5-year follow-up Diabetes Care 24 1 2001 78 83
23. V. Falanga Wound healing and its impairment in the diabetic foot Lancet 366 9498 2005 1736 1743
24. I. Goren, E. Muller, D. Schiefelbein, P. Gutwein, O. Seitz, J. Pfeilschifter, and S. Frank Akt1 controls insulin-driven VEGF biosynthesis from keratinocytes: Implications for normal and diabetes-impaired skin repair in mice The Journal of Investigative Dermatology 129 3 2009 752 764
25. E.W. Gregg, Y. Li, J. Wang, N.R. Burrows, M.K. Ali, D. Rolka, D.E. Williams, and L. Geiss Changes in diabetes-related complications in the United States, 1990-2010 The New England Journal of Medicine 370 16 2014 1514 1523
26. M. Gupta, H. Teoh, M. Kajil, M. Tsigoulis, A. Quan, M.F. Braga, and S. Verma The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients Experimental and Clinical Cardiology 17 4 2012 191 196
27. University of Texas D. Herndon Mechanisms of improved wound healing and protein synthesis of insulin and metformin Retrieved 20 April 2015, from http://clinicaltrials.gov/show/NCT01666665 2015
28. R.S. Hundal, M. Krssak, S. Dufour, D. Laurent, V. Lebon, and V. Chandramouli G.I. Shulman Mechanism by which metformin reduces glucose production in type 2 diabetes Diabetes 49 12 2000 2063 2069
29. Y. Ishibashi, T. Matsui, M. Takeuchi, and S. Yamagishi Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression Hormone and Metabolic Research 44 12 2012 891 895
30. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 6662 1998 82 86
31. S.E. Kahn, S.M. Haffner, G. Viberti, W.H. Herman, J.M. Lachin, and B.G. Kravitz G. Diabetes Outcome Progression Trial Study Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT) Diabetes Care 33 1 2010 177 183
32. T.J. Koh, and L.A. DiPietro Inflammation and wound healing: The role of the macrophage Expert Reviews in Molecular Medicine 13 2011 e23
33. C. Koliaki, and J. Doupis Incretin-based therapy: A powerful and promising weapon in the treatment of type 2 diabetes mellitus Diabetes Therapy 2 2 2011 101 121
34. K. Koshiba, M. Nomura, Y. Nakaya, and S. Ito Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis The Journal of Medical Investigation 53 1-2 2006 87 94
35. M. Lamkanfi, J.L. Mueller, A.C. Vitari, S. Misaghi, A. Fedorova, and K. Deshayes V.M. Dixit Glyburide inhibits the Cryopyrin/Nalp3 inflammasome The Journal of Cell Biology 187 1 2009 61 70
36. S. Langer, F. Born, A. Breidenbach, A. Schneider, E. Uhl, and K. Messmer Effect of C-peptide on wound healing and microcirculation in diabetic mice European Journal of Medical Research 7 11 2002 502 508
37. C.H. Lee, M.J. Hsieh, S.H. Chang, Y.H. Lin, S.J. Liu, and T.Y. Lin J.H. Juang Enhancement of diabetic wound repair using biodegradable nanofibrous metformin-eluting membranes: In vitro and in vivo ACS Applied Materials & Interfaces 6 6 2014 3979 3986
38. S.J. Leibovich, and R. Ross The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum The American Journal of Pathology 78 1 1975 71 100
39. L. Li, J. Shen, M.M. Bala, J.W. Busse, S. Ebrahim, and P.O. Vandvik X. Sun Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: Systematic review and meta-analysis of randomised and non-randomised studies BMJ 348 2014 g2366
40. Y.C. Lim, M.P. Bhatt, M.H. Kwon, D. Park, S. Na, Y.M. Kim, and K.S. Ha Proinsulin C-peptide prevents impaired wound healing by activating angiogenesis in diabetes The Journal of Investigative Dermatology 135 1 2015 269 278
41. M.H. Lima, A.M. Caricilli, L.L. de Abreu, E.P. Araujo, F.F. Pelegrinelli, and A.C. Thirone M.J. Saad Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: A double-blind placebo-controlled clinical trial PloS One 7 5 2012 e36974
42. M.A. Loots, E.N. Lamme, J. Zeegelaar, J.R. Mekkes, J.D. Bos, and E. Middelkoop Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds The Journal of Investigative Dermatology 111 5 1998 850 857
43. J.A. Lovshin, and D.J. Drucker Incretin-based therapies for type 2 diabetes mellitus Nature Reviews. Endocrinology 5 5 2009 262 269
44. T. Lucas, A. Waisman, R. Ranjan, J. Roes, T. Krieg, and W. Muller S.A. Eming Differential roles of macrophages in diverse phases of skin repair Journal of Immunology (Baltimore, Md.: 1950) 184 7 2010 3964 3977
45. A. Makdissi, H. Ghanim, M. Vora, K. Green, S. Abuaysheh, and A. Chaudhuri P. Dandona Sitagliptin exerts an antinflammatory action The Journal of Clinical Endocrinology and Metabolism 97 9 2012 3333 3341
46. R. Marfella, F.C. Sasso, M.R. Rizzo, P. Paolisso, M. Barbieri, and V. Padovano S. Canonico Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes Experimental Diabetes Research 2012 2012 892706
47. P. Martin, and S.J. Leibovich Inflammatory cells during wound repair: The good, the bad and the ugly Trends in Cell Biology 15 11 2005 599 607
48. M.A. Martinez-Jimenez, J. Aguilar-Garcia, R. Valdes-Rodriguez, M.A. Metlich-Medlich, L.J. Dietsch, and F.I. Gaitan-Gaona J.M. Sanchez-Aguilar Local use of insulin in wounds of diabetic patients: higher temperature, fibrosis, and angiogenesis Plastic and Reconstructive Surgery 132 6 2013 1015e 1019e
49. R. Mirza, L.A. DiPietro, and T.J. Koh Selective and specific macrophage ablation is detrimental to wound healing in mice The American Journal of Pathology 175 6 2009 2454 2462
50. R.E. Mirza, M.M. Fang, W.J. Ennis, and T.J. Koh Blocking interleukin-1beta induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes Diabetes 62 7 2013 2579 2587
51. R.E. Mirza, M.M. Fang, M.L. Novak, N. Urao, A. Sui, W.J. Ennis, and T.J. Koh Macrophage PPAR-gamma and impaired wound healing in type 2 diabetes The Journal of Pathology 236 2015 433 444
52. R.E. Mirza, M.M. Fang, E.M. Weinheimer-Haus, W.J. Ennis, and T.J. Koh Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice Diabetes 63 3 2014 1103 1114
53. P. Mohanty, A. Aljada, H. Ghanim, D. Hofmeyer, D. Tripathy, and T. Syed P. Dandona Evidence for a potent antiinflammatory effect of rosiglitazone The Journal of Clinical Endocrinology and Metabolism 89 6 2004 2728 2735
54. P. Mohanty, W. Hamouda, R. Garg, A. Aljada, H. Ghanim, and P. Dandona Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes The Journal of Clinical Endocrinology and Metabolism 85 8 2000 2970 2973
55. N. Nath, M. Khan, M.K. Paintlia, I. Singh, M.N. Hoda, and S. Giri Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis Journal of Immunology (Baltimore, Md.: 1950) 182 12 2009 8005 8014
56. M.L. Novak, and T.J. Koh Phenotypic transitions of macrophages orchestrate tissue repair The American Journal of Pathology 183 5 2013 1352 1363
57. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 3 2001 327 334
58. D.M. Putz, W.S. Goldner, R.S. Bar, W.G. Haynes, and W.I. Sivitz Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy Metabolism 53 11 2004 1454 1461
59. S.M. Rangwala, and M.A. Lazar Peroxisome proliferator-activated receptor gamma in diabetes and metabolism Trends in Pharmacological Sciences 25 6 2004 331 336
60. G.E. Reiber, and G.J. Raugi Preventing foot ulcers and amputations in diabetes Lancet 366 9498 2005 1676 1677
61. G.E. Reiber, L. Vileikyte, E.J. Boyko, M. del Aguila, D.G. Smith, L.A. Lavery, and A.J. Boulton Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings Diabetes Care 22 1 1999 157 162
62. O. Rezvani, E. Shabbak, A. Aslani, R. Bidar, M. Jafari, and S. Safarnezhad A randomized, double-blind, placebo-controlled trial to determine the effects of topical insulin on wound healing Ostomy/Wound Management 55 8 2009 22 28
63. M.R. Rizzo, M. Barbieri, R. Marfella, and G. Paolisso Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition Diabetes Care 35 10 2012 2076 2082
64. A. Salminen, J.M. Hyttinen, and K. Kaarniranta AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan Journal of Molecular Medicine (Berlin, Germany) 89 7 2011 667 676
65. A.J. Scheen A review of gliptins for 2014 Expert Opinion on Pharmacotherapy 16 1 2015 43 62
66. D. Schiefelbein, O. Seitz, I. Goren, J.P. Dissmann, H. Schmidt, and M. Bachmann S. Frank Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: Implications for diabetes-impaired skin repair Molecular Pharmacology 74 4 2008 952 963
67. C. Schurmann, A. Linke, K. Engelmann-Pilger, C. Steinmetz, M. Mark, and J. Pfeilschifter S. Frank The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice The Journal of Pharmacology and Experimental Therapeutics 342 1 2012 71 80
68. Z. Shah, T. Kampfrath, J.A. Deiuliis, J. Zhong, C. Pineda, and Z. Ying S. Rajagopalan Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis Circulation 124 21 2011 2338 2349
69. L. Shi, G.S. Tan, and K. Zhang Relationship of the serum CRP level with the efficacy of metformin in the treatment of type 2 diabetes mellitus: A meta-analysis Journal of Clinical Laboratory Analysis 2014 10.1002/jcla.21803
70. R.I. Shorr, W.A. Ray, J.R. Daugherty, and M.R. Griffin Individual sulfonylureas and serious hypoglycemia in older people Journal of the American Geriatrics Society 44 7 1996 751 755
71. S.K. Vijay, M. Mishra, H. Kumar, and K. Tripathi Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes Acta Diabetologica 46 1 2009 27 33
72. E. Wertheimer, N. Spravchikov, M. Trebicz, M. Gartsbein, D. Accili, and I. Avinoah T. Tennenbaum The regulation of skin proliferation and differentiation in the IR null mouse: Implications for skin complications of diabetes Endocrinology 142 3 2001 1234 1241
73. J. Zhang, X. Huang, and L. Wang Pioglitazone inhibits the expression of matrix metalloproteinase-9, a protein involved in diabetes-associated wound healing Molecular Medicine Reports 10 2 2014 1084 1088
74. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp Thioredoxin-interacting protein links oxidative stress to inflammasome activation Nature Immunology 11 2 2010 136 140